Precision Medicine - Biomarkers & Diagnostics

Acobiom, a remarkable experience in international R&D collaborations

Acobiom is or has been involved in several national and international research programs focused on the discovery of biomarkers, on the development of innovative diagnostics and therapeutics.

R-Link logo
European / H2020 grants

Optimizing response to Lithium treatment through personalized evaluation of individuals with bipolar I disorder.

Coordination: Frank Bellivier’s team (AP-HP, Paris, France).

Oncosnipe logo
Bpifrance funds

Development of tools of diagnostic and of the research of new therapeutic targets for patients resistant to cancer treatments.

Coordination: Oncodesign (France).

Acobiom logo
Bpifrance funds

Role of mast cell in neurology – Exploitation of an innovative therapeutic approach in Alzheimer’s disease. 

Coordination: AB Science (France).

Acobiom logo
Bpifrance funds

Improving the Predictivity of Activity and Selectivity of Protein Inhibitor Kinases in Oncology.

Coordination: AB Science (France).

Conco logo
European/FP6 grants

Applied venomics of the cone snail species Conus consors for an accelerated, cheaper, safer and more ethical production of innovative biomedical drugs.

Coordination: Atheris (Switzerland)

Sysco Logo
European/FP6 grants

Systematic functional analysis of intracellular parasitism as a model of genomes conflict
Example of Leishmania.

Coordination: Biobase (Germany)

USDEP logo
European/FP6 grants

Capture and enrichment of emerging pathogens for multiple and ultra-sensitive diagnostics.

Coordination: Robert Koch Institute (Germany)

Acobiom Logo
PHRC grants

Study of cell differentiation genes in patients suffering from Acute Myeloid Leukemia, Chronic Myeloid Leukemia and Chronic Myeloid Monocytic Leukemia.

Coordination: Nimes hospital (France)